1. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Issue 3 (19th March 2015) Authors: Miehlke, Stephan; Hruz, Petr; Vieth, Michael; Bussmann, Christian; von Arnim, Ulrike; Bajbouj, Monther; Schlag, Christoph; Madisch, Ahmed; Fibbe, Christiane; Wittenburg, Henning; Allescher, Hans Dieter; Reinshagen, Max; Schubert, Stefan; Tack, Jan; Müller, Michaela; Krummenerl, Patrick; Arts, Jor... Journal: Gut Issue: Volume 65:Issue 3(2016) Page Start: 390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Issue 6 (13th May 2010) Authors: Reinisch, Walter; Angelberger, Sieglinde; Petritsch, Wolfgang; Shonova, Olga; Lukas, Milan; Bar-Meir, Simon; Teml, Alexander; Schaeffeler, Elke; Schwab, Matthias; Dilger, Karin; Greinwald, Roland; Mueller, Ralph; Stange, Eduard F; Herrlinger, Klaus R Journal: Gut Issue: Volume 59:Issue 6(2010) Page Start: 752 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial. Issue 1 (February 2018) Authors: Dignass, Axel; Schnabel, Robert; Romatowski, Jacek; Pavlenko, Vladimir; Dorofeyev, Andrey; Derova, Jelena; Jonaitis, Laimas; Dilger, Karin; Nacak, Tanju; Greinwald, Roland Journal: United European Gastroenterology journal Issue: Volume 6:Issue 1(2018) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of a novel high‐dose mesalazine tablet in mild to moderate active ulcerative colitis: a double‐blind, multicentre, randomised trial. Issue 1 (1st February 2018) Authors: Dignass, Axel; Schnabel, Robert; Romatowski, Jacek; Pavlenko, Vladimir; Dorofeyev, Andrey; Derova, Jelena; Jonaitis, Laimas; Dilger, Karin; Nacak, Tanju; Greinwald, Roland Journal: United European Gastroenterology journal Issue: Volume 6:Issue 1(2018) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Issue 1 (25th November 2014) Authors: Münch, Andreas; Bohr, Johan; Miehlke, Stephan; Benoni, Cecilia; Olesen, Martin; Öst, Åke; Strandberg, Lars; Hellström, Per M; Hertervig, Erik; Armerding, Peter; Stehlik, Jiri; Lindberg, Greger; Björk, Jan; Lapidus, Annika; Löfberg, Robert; Bonderup, Ole; Avnström, Sören; Rössle, Martin; Dilger, K... Journal: Gut Issue: Volume 65:Issue 1(2016) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial. (1st September 2014) Authors: Dignass, Axel; Stoynov, Simeon; Dorofeyev, Andrey E.; Grigorieva, Galina A.; Tomsová, Eva; Altorjay, István; Tuculanu, Daniel; Bunganič, Ivan; Pokrotnieks, Juris; Kupčinskas, Limas; Dilger, Karin; Greinwald, Roland; Mueller, Ralph Journal: Journal of Crohn's and colitis Issue: Volume 8:Number 9(2014) Page Start: 970 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Suicidal attempt with eliglustat overdose. Issue 1 (4th October 2022) Authors: Nadler, Johannes; Hermanns‐Clausen, Maren; Dilger, Karin Journal: JIMD reports Issue: Volume 64:Issue 1(2023) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study. Issue 2 (February 2015) Authors: Kreisel, Wolfgang; Deibert, Peter; Kupcinskas, Limas; Sumskiene, Jolanta; Appenrodt, Beate; Roth, Susanne; Neagu, Michaela; Rössle, Martin; Zipprich, Alexander; Caca, Karel; Ferlitsch, Arnulf; Dilger, Karin; Mohrbacher, Ralf; Greinwald, Roland; Sauerbruch, Tilman Journal: Digestive and liver disease Issue: Volume 47:Issue 2(2015) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study. Issue 2 (February 2015) Authors: Kreisel, Wolfgang; Deibert, Peter; Kupcinskas, Limas; Sumskiene, Jolanta; Appenrodt, Beate; Roth, Susanne; Neagu, Michaela; Rössle, Martin; Zipprich, Alexander; Caca, Karel; Ferlitsch, Arnulf; Dilger, Karin; Mohrbacher, Ralf; Greinwald, Roland; Sauerbruch, Tilman Journal: Digestive and liver disease Issue: Volume 47:Issue 2(2015) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗